Joshua Drumm - Valneva SE VP Relations

AYJ Stock  EUR 1.97  0.03  1.50%   

Insider

Joshua Drumm is VP Relations of Valneva SE
Phone33 2 28 07 37 10
Webhttps://valneva.com

Valneva SE Management Efficiency

The company has return on total asset (ROA) of (0.185) % which means that it has lost $0.185 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8614) %, meaning that it generated substantial loss on money invested by shareholders. Valneva SE's management efficiency ratios could be used to measure how well Valneva SE manages its routine affairs as well as how well it operates its assets and liabilities.
Valneva SE has accumulated 50.73 M in total debt with debt to equity ratio (D/E) of 1.45, which is about average as compared to similar companies. Valneva SE has a current ratio of 1.21, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Valneva SE until it has trouble settling it off, either with new capital or with free cash flow. So, Valneva SE's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Valneva SE sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Valneva to invest in growth at high rates of return. When we think about Valneva SE's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christopher LohmannTalanx AG
55
James DevensSuperior Plus Corp
N/A
Edward KirnbauerIdentiv
58
Manfred MuellerIdentiv
53
Edgar PulsTalanx AG
50
Geoffery MerszeiOrigin Agritech
68
Fei WangOrigin Agritech
40
James KangOrigin Agritech
54
Justin ScarpullaIdentiv
50
Larry CordellOrigin Agritech
56
Jan WickeTalanx AG
55
Ingrid EngstromSIVERS SEMICONDUCTORS AB
59
Bjorn NorrbomSIVERS SEMICONDUCTORS AB
72
Allison MillerNMI Holdings
N/A
Amir KhoshniyatiIdentiv
N/A
Erik WiklundSIVERS SEMICONDUCTORS AB
49
Yasheng YangOrigin Agritech
51
Torsten LeueTalanx AG
57
Steven HumphreysIdentiv
62
Dag SigurdSIVERS SEMICONDUCTORS AB
73
Robert SmithNMI Holdings
53
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France. VALNEVA SE is traded on Frankfurt Stock Exchange in Germany. Valneva SE (AYJ) is traded on Frankfurt Exchange in Germany and employs 762 people.

Management Performance

Valneva SE Leadership Team

Elected by the shareholders, the Valneva SE's board of directors comprises two types of representatives: Valneva SE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Valneva. The board's role is to monitor Valneva SE's management team and ensure that shareholders' interests are well served. Valneva SE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Valneva SE's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frederic Jacotot, Vice President, General Counsel, Member of the Management Board, Member of the Executive Committee , General Secretary
AnneMarie Graffin, Independent Member of the Supervisory Board
Johanna Pattenier, Member of the Supervisory Board
Thomas Lingelbach, Chairman of the Management Board, President, Chief Executive Officer, Member of the Management Board
Louisa ShawMarotto, Vice Chairman of the Supervisory Board, Independent Director
Gerald Strohmaier, VP Resource
Frances Muir, Site Director Livingston, Member of the Executive Committee
Peter Buhler, CFO Member
Wolfgang Bender, Chief Medical Officer, Member of the Management Board, Member of the Executive Committee
Joshua Drumm, VP Relations
Dipal Patel, Chief Board
Franck Grimaud, Chief Executive Officer, Member of the Management Board, Member of the Executive Committee
Janet Hoogstraate, Chair of the Management Board of Valneva Sweden AB, Member of the Executive Committee
James Sulat, Independent Vice Chairman of the Supervisory Board
Franck MBA, Chief Gen
Frederic Grimaud, Chairman of the Supervisory Board
Juan Jaramillo, Chief Medical Officer, Member of the Management Board
David Lawrence, Chief Financial Officer, Member of the Management Board
Klaus Schwamborn, Vice President - Discovery Research & Innovation, Member of the Executive Committee
JuanCarlos MD, Chief Board
Michael Moehlen, Vice President Corporate Technical Development, Member of the Executive Committee
Andreas Meinke, Vice President Pre-clinical & Translational Research, Member of the Executive Committee
Perry Celentano, Interim Chief Operating Officer
Olivier Jankowitsch, Vice President Global Supply Operations, Member of the Executive Committee
Laetitia BachelotFontaine, Investor Relations Manager
Manfred Tiefenbacher, Vice President - Finance, Member of the Executive Committee
Thomas Casdagli, Member of the Supervisory Board - Representative of MVM Partners LLP
Jason Golan, Vice President Commercial Operations, Member of the Executive Committee
Sharon Tetlow, Member of the Supervisory Board

Valneva Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Valneva SE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Valneva Stock

Valneva SE financial ratios help investors to determine whether Valneva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.